SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchère; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus Mall; Kirsten Beyer; Jobst Röhmel; Sebastian Voigt; Jürgen Schmitz; Stefan Miltenyi; Ilja Demuth; Marcel A. Müller; Andreas C. Hocke; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M. Corman; Claudia Giesecke‐Thiel; Leif Erik Sander; Andreas Thiel

doi:10.1038/s41586-020-2598-9

Keywords

CoronavirusEpitopeAsymptomaticGlycoproteinImmunologyVirologyC-reactive proteinPopulationMedicineBiologyCoronavirus disease 2019 (COVID-19)DiseaseAntibodyInflammationGeneticsInfectious disease (medical specialty)Pathology

Affiliated Institutions

Related Publications

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat , Daniel Stadlbauer , Shirin Strohmeier +27 more

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and identification of human SARS-CoV-2 seroconverters. This assay does not require the handli...

2020 Nature Medicine 1934 citations

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers , Fangzhu Zhao , Deli Huang +31 more

Protective neutralizing antibodies Antibodies produced by survivors of coronavirus disease 2019 (COVID-19) may be leveraged to develop therapies. A first step is identifying neu...

2020 Science 1467 citations

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Syed Faraz Ahmed , Ahmed Abdul Quadeer , Matthew R. McKay

The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an immine...

2020 Viruses 1203 citations

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

José Mateus , Alba Grifoni , Alison Tarke +23 more

Preexisting immune response to SARS-CoV-2 Robust T cell responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus occur in most individuals with corona...

2020 Science 1244 citations

SARS-CoV-2 vaccines in development

Florian Krammer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Publication Info

Year: 2020
Type: article
Volume: 587
Issue: 7833
Pages: 270-274
Citations: 1374
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1374

OpenAlex

Cite This

APA Style

                            
                                
                                    Julian Braun, 
                                
                                    Lucie Loyal, 
                                
                                    Marco Frentsch
                                
                                et al.
                            
                            (2020). 
                            SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. 
                            Nature
                            , 587
                            (7833)
                            , 270-274.
                            https://doi.org/10.1038/s41586-020-2598-9
                        

Identifiers

DOI: 10.1038/s41586-020-2598-9